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Abstract Objective: To compare
two methods of assessing a change
in stroke volume in response to fluid
challenge: esophageal Doppler and
thermodilution with the pulmonary
artery catheter. Design: Prospective
study. Setting: Department of Inten-
sive Care of a university medical
center. Patients: 19 adult patients,
intubated and sedated, with a pulmo-
nary catheter and a clinical indica-
tion for a fluid challenge. Interven-
tions: Two examiners independently
assessed the effect of a fluid chal-
lenge on stroke volume and cardiac
output with esophageal Doppler.
Thermodilution performed by an in-
dependent clinician was used as the
reference. Between-method variation
and interobserver variability of the
Doppler method were assessed.
Measurements and results: There
were no differences in stroke volume
and cardiac output before volume
challenge when measured with either
of the two methods or by the two ex-
aminers using the esophageal Dopp-
ler. Despite a small bias between the
methods and the two examiners us-
ing the esophageal Doppler (overall
bias for cardiac output 0.3 l/min), 
the precision was poor (1.8 l/min). 
Conclusions: The esophageal Dopp-
ler method is a non-invasive alterna-
tive to the pulmonary artery catheter
for the assessment of stroke volume
in critically ill patients. Measure-
ment of stroke volume response to
fluid challenge using esophageal
Doppler shows substantial interob-
server variability. Despite the poor
precision between methods and in-
vestigators, similar directional chang-
es in stroke volume can be measured.
Keywords Cardiac output · Stroke
volume · Esophageal Doppler · 
Thermodilution · Volume challenge
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Introduction
Hypovolemia in patients in intensive care units (ICU) is
common. The assessment of volume status is not
straightforward and must often be based on hemody-
namic response to a fluid challenge. The response to 
a fluid challenge can be assessed by observing changes
in stroke volume. While cardiac output measurement 
using a pulmonary artery (PA) catheter (the thermodilu-
tion method) remains the standard in clinical practice 
[1, 2, 3, 4], stroke volume monitoring with esophageal
Doppler provides an attractive, less invasive alternative
[5, 6, 7].
Esophageal Doppler was first introduced in the early
1970s and more recently has been successfully approved
for optimizing fluid management perioperatively and in
intensive care patients [8, 9, 10]. Although stroke vol-
ume measurement using esophageal Doppler is simple in
principle, several sources of error may interfere with its
clinical application. The aim of this study was to assess
the hemodynamic changes occurring after a clinically in-
dicated volume load, using both the esophageal Doppler
and the thermodilution method. Furthermore, we aimed
to assess the inter-investigator variability of the esopha-
geal Doppler method.
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Materials and methods
The study was approved by the Ethics Committee of the Canton of
Bern, according to the Declaration of Helsinki. Since informed
consent by the patients or the family was not considered possible
due to the emergency clause, an independent physician was desig-
nated to give consent.
Inclusion and exclusion criteria
The indication for inclusion in the study was the treating intensive
care resident’s decision to give a volume challenge. The inclusion
criteria were: age greater than 16 years; patient on mechanical
ventilation and sedated; and pulmonary catheter (Edwards Life
Sciences, Irvine, Calif.) already in place. The exclusion criteria
were: need for an urgent volume infusion (volume load given
within 15 min to quickly stabilize a hemodynamically unstable sit-
uation); atrial fibrillation or flutter; relevant intra-cardiac shunt-
ing; presence of an intra-aortic balloon pump; fluid requirement of
>500 ml within the last 2 h or changing requirements of vasoac-
tive drugs (>20% within the last 30 min); coagulation abnormali-
ties (increased thrombin time, thrombocytes <100×103µ/l); and
prior enoral or esophageal surgery.
Esophageal Doppler
The esophageal Doppler probe (Cardio Q, Deltex Medical Limit-
ed, Chichester, UK) is approved for clinical use, and is routinely
used in several institutions [11, 12, 13]. It is placed into the esoph-
agus either through the mouth or the nose. The esophageal probe
(90 cm length, 6 mm diameter) holds a 5.1-MHz Doppler device
which sends out ultrasound signals at an angle of 45°. Based on
the relation between emitted and reflected waves, the blood flow
velocity of the descending aorta can be computed. Blood flow ve-
locity is measured at a depth of 35–40 cm after the dental row.
Placement is assumed to be correct if well-reproducible, sharply
defined wave forms can be seen on the screen of the monitor.
Introduction of the method
The monitoring of an optimal Doppler signal depends largely on
the examiner [14]. According to the manufacturer, reliable results
can be obtained after five measurements (Operation Handbook,
Deltex Medical Limited, Chichester, UK). In our department, all
attending specialists (n=10) received a theoretical introduction and
a practical demonstration of the method, and felt confident with
the method within 8 weeks. The exact number of measurements
performed to reach this goal was not registered.
Study protocol
The protocol is shown in Fig. 1. After the resident made the deci-
sion for volume administration, the independent physician (a se-
nior specialist of the Department of Anesthesia) rechecked inclu-
sion and exclusion criteria. If appropriate, the patient was included
in the study. The study coordinator (one of the co-authors) inserted
the Doppler probe. The probe was placed into the esophagus either
through the mouth or the nose to a depth of 35–40 cm from the
dental row. The sensor was placed in an anterior direction. Correct
placement was assumed when well-reproducible, sharply defined
wave forms appeared on the screen of the monitor.
The monitor was connected, and two of eight attending spe-
cialists not involved in the care of the patient were defined as ex-
aminers based on availability. Stroke volume and cardiac output
were measured with the esophageal Doppler by the first examiner
and then by the second. The study coordinator changed the posi-
tion of the probe after the first measurement, so that the second
examiner was blinded to the results obtained by the first examiner.
After the Doppler measurements, the treating resident measured
cardiac output with the thermodilution method using a cardiac out-
put monitor (Vigilance TM, Baxter Lab, Santa Ana, Calif.). There
were four randomly assigned measurements over the entire respi-
ratory cycle using 10 ml of 0.9% sodium chloride at room temper-
ature [15] with maximal injection speed. The arithmetic mean of
these four measurements was calculated. The clinician was blind-
ed to the results obtained by the two examiners who used the
Doppler measurement. After all the measurements had been 
performed, the patient was given 200 ml of a gelatin solution
(Physiogel, B. Braun, Emmenbrücke, Switzerland) over 15 min 
either via a peripheral venous line or through the port of the pul-
monary artery catheter. After the volume load, stroke volume mea-
surements were performed by the second examiner, followed by
the first examiner, hence in reverse order. Between the measure-
ments, the probe was displaced by the study coordinator and the
examiner had to reposition it. Next, the resident repeated the mea-
surements using the thermodilution method. The time interval 
between two sets of Doppler measurements was a few minutes,
depending on how fast the second investigator found the optimal
signal. Thermodilution cardiac output was measured immediately
after the second Doppler measurement. During each measurement
(Doppler and thermodilution method), representative values for
systolic and diastolic blood pressure, pulmonary artery pressure,
pulmonary artery wedge pressure, and central venous pressure
were recorded.
Statistics
With the relatively small number of examinations (n=20) we used
non-parametric tests. To compare the two methods before volume
load, the Kruskal-Wallis Test (heart rate, all pressure values) and
the Mann-Whitney U test (cardiac output, stroke volume) were
used. For the two latter parameters the mean Doppler values of the
two examiners were computed. The effect of the volume challenge
for both methods was examined with the Wilcoxon test. The same
test was used to analyze the results of both examiners with the
Doppler: the Mann-Whitney U test was used to compare the val-
ues before the volume challenge, and the Wilcoxon test was used
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Fig. 1 Study protocol
to assess the effect of volume administration. Statistical signifi-
cance was assumed at a p value <0.05. Results are given as mean
values (±SD), if not stated otherwise.
Results
Between September 2000 and April 2001, 19 patients
participated in the study and 20 measurements were per-
formed (1 patient had measurements on two different
days). There were 6 women and 13 men with a median
age of 62 years (range 21–78 years) and a median Sim-
plified Acute Physiologic Score II (SAPS II) [16] of 47
(range 25–87; Table 1).
Thirteen of the 19 patients were on one or more 
continuously infused vasoactive drugs (see Table 1). Ta-
bles 2 and 3 summarize the results of the hemodynamic
parameters.
There were no significant differences in heart fre-
quency or in the measured pressure values between the
Doppler and thermodilution methods (Table 2). While
heart rate and systemic blood pressure remained constant
during the whole procedure, mean pulmonary artery
pressure and central venous pressure increased slightly.
Stroke volume and cardiac output values are displayed in
Table 3. The coefficient of variation of all four bolus
measurements using the thermodilution method was 7%
(4%) before and 8% (6%) after volume load. There were
no differences in stroke volume and cardiac output be-
fore volume challenge when measured with either of the
two methods or by the two examiners using the esopha-
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Table 1 Patient profiles. NPT natrium–nitroprusside, NE norepinephrine, E epinephrine, DOB dobutamine, SAPS Simplified Acute
Physiologic Score, ARDS adult respiratory distress syndrome, MODS multiple organ dysfunction syndrome
Patient no. Age (years) SAPS Gender Diagnosis Vasoactive agents
1 73 54 M Sepsis NPT 4 mg/h
2 51 33 M Septic shock None
3 78 55 M Sepsis DOB 20 mg/h
4 21 46 M Multi-system trauma DOB 20 mg/h; NE 120 mcg/h
5 67 32 M Aortic dissection NE 1300 mcg/h
6 66 43 F Cardiogenic shock None
7 71 39 M Pancreatitis, MODS NE 300 mcg/h
8 42 39 M Sepsis NE 50 mcg/h
9 62 51 F ARDS None
10 63 50 F Mitral insufficiency NE 200 mcg/h
11 68 25 M Myocardial revascularization DOB 15 mg/h
12 47 43 M Head injury NE 800 mcg/h
13 75 47 M Myocardial revascularization NE 200 mcg/h
14 42 65 F Cardiogenic shock None
15 67 63 M Cardiogenic shock E 160 mcg/h
16 64 87 F Aortic dissection DOB 6 mg/h
17 64 87 F Aortic dissection None
18 78 38 M Sepsis DOB 6 mg/h; NE 500 mcg/h
19 61 61 M Sepsis DOB 10 mg/h
20 69 46 M Aortic-valve replacement None
Median (range) 65 (21–78) 47 (25–87) – – –
Table 2 Hemodynamic parameters
Esophageal Esophageal Thermo- pa pb
Doppler Doppler dilution
Investigator 1 Investigator 2
Heart rate before volume (b/min) 102 (15) 102 (16) 102 (16)
After volume (b/min) 101 (16) 102 (17) 101 (16)
Mean arterial pressure before volume (mm Hg) 65 (8) 65 (7) 64 (6)
After volume (mm Hg) 67 (7) 66 (9) 66 (8)
Mean pulmonary–arterial pressure before volume (mm Hg) 26 (5) 26 (5) 26 (5)
After volume (mm Hg) 28 (6) 28 (6) 28 (5) <0.01 <0.01
Central venous pressure before volume (mm Hg) 12 (4) 11 (4) 11 (4)
After volume (mm Hg) 12 (4) 12 (4) 12 (4) 0.03 <0.01
Pulmonary capillary wedge pressure before volume (mm Hg) 14 (3) 14 (3) 14 (3)
After volume (mm Hg) 15 (4) 15 (4) 15 (4) <0.01 <0.01
a p: Effect of volume load (Wilcoxon test): esophageal Doppler
b p: Effect of volume load (Wilcoxon test): thermodilution
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Fig. 2 Esophageal Doppler: investigator 1 vs investigator 2.
Comparison of changes in stroke volume in association with 
volume application. Each line shows the data of 1 patient. Data
markers: values after volume load; triangles: patients with cate-
cholamines (epinephrine, norepinephrine, dobutamine); squares:
patients with natrium–nitroprusside; circles: patients without 
vasoactive agents
Fig. 3 Esophageal Doppler: investigator 1 vs thermodilution.
Comparison of stroke volume change after volume application.
Each line shows the data of one patient. Data markers: values af-
ter volume; triangles: patients with catecholamines (epinephrine,
norepinephrine, dobutamine); squares: patients with natrium–
nitroprusside; circles: patients without vasoactive agents
Fig. 4 Esophageal Doppler: investigator 2 vs thermodilution.
Comparison of stroke volume change after volume application.
Each line shows the data of one patient. Data markers: values af-
ter volume. triangles: patients with catecholamines (epinephrine,
norepinephrine, dobutamine); squares: patients with natrium–
nitroprusside; circles: patients without vasoactive agents
Fig. 5 Bland-Altman graph: investigator 1 vs investigator 2.
Grey data points: value before volume; black data points: value
after volume; triangles: patients with catecholamines (epineph-
rine, norepinephrine, dobutamine); squares: patients with natri-
um–nitroprusside; circles: patients without vasoactive agents;
solid line: mean values; dotted lines: mean values ±1.96 standard
deviation
Table 3 Stroke volume and cardiac output before and after volume challenge
Esophageal Doppler Thermodilution pa pb
Investigator 1 Investigator 2 Mean
Stroke volume before volume (ml) 60 (23) 65 (24) 62 (22) 63 (24)
After volume (ml) 69 (24) 69 (25) 69 (24) 66 (22) <0.01 0.02
Cardiac output before volume (l/min m2) 5.96 (2.12) 6.52 (2.17) 6.24 (1.97) 6.35 (2.30)
After volume (l/min m2) 6.85 (2.03) 6.81 (2.12) 6.83 (1.97) 6.57 (2.26) 0.01 0.09
a p: Effect of volume load (Wilcoxon test): esophageal Doppler
b p: Effect of volume load (Wilcoxon test): thermodilution
geal Doppler. With both methods, and with both examin-
ers using the esophageal Doppler method, there was a
significant increase in the stroke volume after a volume
challenge, while the increase in the cardiac output mea-
sured by thermodilution was not significant (Table 3).
While the overall correlation between the two methods
was relatively good both before and after volume load
(correlation coefficients between 0.6 and 0.9; p<0.01),
individual differences between the methods and the 
examiners using esophageal Doppler were obvious
(Figs. 2, 3, 4). The Bland-Altman analysis (Fig. 5) dem-
onstrates that the bias is small (overall bias for cardiac
output 0.3 l/min) but the precision is poor (1.8 l/min).
Discussion
The main finding of this study was the great variability
in the measured changes in stroke volume after a volume
load, as assessed by two different methods – thermodilu-
tion and esophageal Doppler – as well as by two differ-
ent examiners both using the esophageal Doppler 
method.
There are several possible explanations for these dis-
crepancies. Firstly, the differences could be real, i.e.,
they could reflect an unstable hemodynamic situation.
We investigated critically ill, mechanically ventilated
and sedated patients, who were often dependent on vaso-
active drugs. Their cardiac function may well have
shown greater variance than is normally expected. Con-
sequently, the examiners could have measured correct
values. We could not find differences between patients
with or without vasoactive agents (Figs. 2, 3, 4). Second-
ly, the differences could be due to stimulation of the pa-
tient. The placement and manipulation of the esophageal
probe could have provoked an adrenergic stimulation in
the patient so that the examiners again correctly mea-
sured a change in the hemodynamic situation. The great-
er difference between the examiners using the Doppler
method before the volume load as compared with after-
wards supports this hypothesis. The esophageal probe
had to be placed before the volume load, whereas after
the volume load, the probe remained in situ with a small-
er manipulation. A third explanation could be a study 
bias of the examiners, who eventually were convinced
that they would measure a higher stroke volume at the
second measurement because they were aware that the 
patients received additional volume between the two
measurements; thus, it is possible that the search for the
optimal signal lasted longer during the second measure-
ment. Another explanation for the inter-individual differ-
ences in the obtained hemodynamic parameters is the
fact that the measurements after volume load were per-
formed over a relatively wide time frame for medical
reasons (mean after-fluid loading: 8.6 min; range
1–32 min). Early measurements may not have included
the volume effect, whereas during late measurements the
volume effect may have been abated. Nevertheless, we
could not find a time dependency of changes in stroke
volumes. Moreover, in a few patients the thermodilution
method may well have been incorrect, since the differ-
ences between the four bolus measurements was greater
than the predicted 10% [17]. Finally, when supra-aortic
branches are preferentially perfused, for some reason,
cardiac output and descending aortic blood flow may not
change in parallel.
Several authors have demonstrated that optimizing
cardiac function, i.e., increasing the oxygen delivery to
the tissues perioperatively and in the ICU, improves the
outcome of the patients [18, 19, 20]. In order to increase
stroke volume and cardiac output, preload has to be opti-
mized. The clinical diagnosis of an insufficient preload
is easy in hypovolemic patients but is difficult when
myocardial dysfunction, altered vessel reactivity, and in-
creased endothelial permeability co-exist, e.g., in septic
patients [21, 22] and in patients after cardiac surgery
[23]. The preload and the effect of a volume challenge
can be measured with echocardiography in these pa-
tients, but this technique is not suitable for continuous
monitoring. In these patients, the pulmonary artery cath-
eter is generally used to obtain continuous or semi-con-
tinuous values of cardiac output and other hemodynami-
cally relevant values. This method is invasive and the
overall benefit has been questioned [1,3,4, 24, 26, 27,
28, 29, 30].
As an alternative, esophageal Doppler allows a nonin-
vasive estimation of cardiac output. Since esophageal
Doppler measures aortic blood flow but not the flow to
supra-aortic arteries, the absolute value underestimates
total cardiac output. Furthermore, esophageal Doppler
measures beat-to-beat flow velocity, which is then con-
verted to cardiac output, whereas thermodilution mea-
sures an average cardiac output over a certain time 
(a mean value of several measurements is calculated).
Esophageal Doppler has been used to estimate the prog-
nosis in cardiac surgery patients [31]. Furthermore, initial
hemodynamic values can be obtained faster than with
pulmonary artery catheterization [32]. The use of the
Doppler method has been associated with improved peri-
operative morbidity and shortening of hospital stay [33].
The great inter-individual differences we found be-
tween the measurements of the two examiners using the
Doppler are inconsistent with the results obtained by
others [6, 10, 34]. These authors found a closer inter-in-
dividual correlation between the esophageal Doppler and
continuous thermodilution methods. The most probable
explanation for the difference, however, is lack of expe-
rience with the esophageal Doppler technique. There is a
correlation between the accuracy of the obtained signal
and the training time [14].
Since the aortal diameter is not measured, variability
in accuracy in the absolute values can be expected. A
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significant pathology, such as a rigidity or manifest scle-
rosis of the aorta, results in a discrepancy between esti-
mated and real cardiac output values. There are esopha-
geal Doppler devices with integrated ultrasound that 
allow the aortic diameter to be measured individually.
Using these devices increases the reliability of the cardi-
ac output value [35]; however, since the esophageal
Doppler signal is highly position dependent, and the
method used to define the best signal and its drift over
time may be different both among and between individu-
als, the accuracy of this method remains limited. On the
other hand, poor contractility in some patients may also
have limited the accuracy of the “gold standard” thermo-
dilution method.
Conclusion
We conclude that the esophageal Doppler method is a
non-invasive method for the monitoring of some cardiac
functions. Its use, however, is not as easy as described in
the literature. If the method is not learned systematically,
the probability of obtaining non-reproducible data is
great. Future studies should evaluate the reproducibility
of this method after a standardized teaching period with
final examinations. Nevertheless, this study demon-
strates that a clinically indicated volume load often, but
not always, leads to an increase in stroke volume.
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